SCHEMBL2829771

SCHEMBL2829771

COc1ccc(OCC(=O)N2CCC(N3CCCC3)CC2)cc1

nearest known ligand 0.73

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ACHE P22303 6/20 0.73
KDM4E B2RXH2 5/20 0.66
ALDH1A1 P00352 4/20 0.66
ORAI1 Q96D31 1/20 0.66
CYP2D6 P10635 1/20 0.65
CYP2C19 P33261 1/20 0.65
NPSR1 Q6W5P4 1/20 0.65
POLB P06746 2/20 0.61
FKBP1A P62942 1/20 0.61
TDP1 Q9NUW8 2/20 0.60
TP53 P04637 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.55
MAPK1 P28482 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4379135 0.90 ALDH1A1 (0.73) ACHEKDM4EALDH1A1ORAI1POLB
SCHEMBL4384069 0.88 ALDH1A1 (0.71) ACHEKDM4EALDH1A1ORAI1POLB
SCHEMBL2829286 0.87 ACHE (0.69) ACHEKDM4EALDH1A1ORAI1CYP2D6
SCHEMBL2836569 0.87 ACHE (0.72) ACHEKDM4EALDH1A1CYP2D6CYP2C19
SCHEMBL182672 0.84 ACHE (0.68) ACHEKDM4EALDH1A1CYP2D6CYP2C19
SCHEMBL2828800 0.84 ACHE (0.67) ACHEKDM4EALDH1A1CYP2D6CYP2C19
SCHEMBL3767766 0.83 ACHE (0.68) ACHEKDM4EALDH1A1ORAI1POLB
SCHEMBL2833225 0.82 KMT2A (0.80) ACHEKDM4EALDH1A1FKBP1ATDP1
SCHEMBL2832012 0.81 ACHE (0.64) ACHEKDM4EALDH1A1CYP2D6CYP2C19
SCHEMBL2831262 0.81 NPC1 (0.76) ACHEKDM4EALDH1A1CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 EP claimed
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 EP disclosed
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 EP disclosed
US-7064135-B2 Substituted piperidines NOVO NORDISK INC. (DK) 2006-06-20 US disclosed